Live feed08:00:00·1558dPRReleasevia QuantisnowEiger's Single-dose Peginterferon Lambda for COVID-19 Reduced Risk of Hospitalization or ER Visits by 50% in a Predominantly Vaccinated Population in Phase 3 TOGETHER StudyByQuantisnow·Wall Street's wire, on your screen.EIGR· Eiger BioPharmaceuticals Inc.Health Care
